# A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-multicenter-study-of-body-mass-index-in-cancer-patients-treated-with-anti-pd-1/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alessio Cortellini,Melissa Bersanelli,Sebastiano Buti,Katia Cannita,Daniele Santini,Fabiana Perrone,Raffaele Giusti,Marcello Tiseo,Maria Michiara,Pietro Di Marino,Nicola Tinari,Michele De Tursi,Federica Zoratto,Enzo Veltri,Riccardo Marconcini,Francesco Malorgio,Marco Russano,Cecilia Anesi,Tea Zeppola,Marco Filetti,Paolo Marchetti,Andrea Botticelli,Gian Carlo Antonini Cappellini,Federica De Galitiis,Maria Giuseppa Vitale,Francesca Rastelli,Federica Pergolesi,Rossana Berardi,Silvia Rinaldi,Marianna Tudini,Rosa Rita Silva,Annagrazia Pireddu,Francesco Atzori,Rita Chiari,Biagio Ricciuti,Andrea De Giglio,Daniela Iacono,Alain Gelibter,Mario Occhipinti,Alessandro Parisi,Giampiero Porzio,Maria Concetta Fargnoli,Paolo A. Ascierto,Corrado Ficorella,Clara Natoli |
| Citations | 422 |
| DOI | 10.1186/s40425-019-0527-y |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jitc.bmj.com/content/jitc/7/1/57.full.pdf |
| OpenAlex ID | https://openalex.org/W2925088208 |
| PMID | 30813970 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Sebastiano Buti](https://scholariq.org/researchers/sebastiano-buti/)
- [Biagio Ricciuti](https://scholariq.org/researchers/biagio-ricciuti/)
- [Marcello Tiseo](https://scholariq.org/researchers/marcello-tiseo/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Risks and Factors](https://scholariq.org/topics/cancer-risks-and-factors/)
- [Multiple and Secondary Primary Cancers](https://scholariq.org/topics/multiple-and-secondary-primary-cancers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.